CD39 and CD73 play a pivotal role in tumor immunosuppression through converting ATP and ADP to AMP and then to adenosine, resulting in immunosuppression and subsequently the onset and progression of tumor growth 92-94. The gene discussed is ENTPD1; the disease is neoplasm.